Senores Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENORES PHARMS
SENORES PHARMS has fifty-one approved drugs.
Summary for Senores Pharms
| US Patents: | 0 |
| Tradenames: | 47 |
| Ingredients: | 47 |
| NDAs: | 51 |
Drugs and US Patents for Senores Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharms | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 214089-001 | Oct 1, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Senores Pharms | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET;ORAL | 075584-001 | Feb 7, 2000 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Senores Pharms | TOPIRAMATE | topiramate | CAPSULE;ORAL | 218642-002 | Oct 10, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Senores Pharms | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | candesartan cilexetil; hydrochlorothiazide | TABLET;ORAL | 202965-002 | Jun 3, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
